Cost-effectiveness of telbivudine-based optimization and entecavir monotherapy in patients with HBeAg- positive chronic hepatitis BYE Xiao-guang, OUYANG Ren-jie1053-1056,1057
Analysis of associations between spleen stiffness and esophageal-gastric varices in patients with HBV- related liver cirrhosis receiving anti-viral treatmentSHI Hai-yan, XU Min, DENG Hao-hui, CHEN Keng, GAO Hong-bo, ZHANG Shu-mei, LIAO Bao-lin1057-1060
Expression and significance of IL-21 in patients infected with hepatitis B virus at different stagesYAO Jia-yan, CHAO Kang, LI Min-rui, WU Yan-qin, YE Jun-zhao, ZHONG Bi-hui1061-1064
A randomized study of de novo combination therapy lamivudine plus adefovir in HBeAg-positive chronic hepatitis B patients with genotype B/CLIU Huai-e, YOU Jing, CHEN Hong-ying, FAN Jing-hua, LIU Hua, ZHANG Ru-yi, RAO Shao-feng, MA Si-jia1065-1068
HBsAg quantification in prediction of the long-term efficacy of interferon for chronic hepatitis BYANG Yang, YANG Long, JIANG Xue-hua, CHEN Zhi-yong1068-1071
Relationship between HBV DNA level, expression of PD-1 on CTL and liver functions in patients with hepatitis B virus cirrhosisWANG Dong, GU Xi-bing, ZHU Yin-fang, DAI Ya-ping, TANG Qin1072-1075
Construction of recombinant eukaryotic expression plasmid containing 1.3-fold-overlength genome of HBV and its expression in Huh7 cellsLU Ren-fei, WU Yue-ping, SUN Wei, BAO Jing1075-1078
Antiviral efficacy of adefovir ester on fatty liver of HBeAg positive patients with chronic hepatitis BWANG Yan-ling, ZHANG Bing, LI Bing-qing1079-1081
Effect of APETx2 on the expression of ASIC3 in dorsal root ganglia in rat AGML modelXU Shao-qun, TU Wei-feng, XI Wen-bin, WEN Jun-lin, ZHOU Hong-yan, JIANG Qun, ZHAO Gao-feng1088-1091
Effects of ginkgo flavone on the expression of TLR4 and NF-κB in the liver of mice with nonalcoholic fatty liver diseaseBAI Ji-hong, LIANG Zhi-qing, ZHAO Ri-hong, LIU Yan-hua, LIN Qiu-xiang, ZHAO Xue1091-1095
